Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)

DiscussionThe Empire HF trial will elucidate the effects and modes of action of empagliflozin in HFrEF patients with and without T2D and provide important mechanistic data which will complement ongoing event-driven trials.Trial registrationClinicaltrialsregister.eu, EudraCT Number2017-001341-27. Registered on 29 May 2017.ClinicalTrials.gov,NCT03198585. Registered on 26 June 2017.
Source: Trials - Category: Research Source Type: clinical trials